Christopher A Lemmon

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Molecular Dynamics

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher A Lemmon, Jie Zhou, Brian P Hobbs, Nathan A Pennell
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States. JCO precision oncology 7 (2023)
Christopher A Lemmon, Jie Zhou, Brian P Hobbs, Nathan A Pennell
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States. JCO precision oncology 7 (2023)
Christopher A Lemmon, Jie Zhou, Brian P Hobbs, Nathan A Pennell
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States. JCO precision oncology 7 (2023)
Christopher A Lemmon, Emily C Zabor, Nathan A Pennell
Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer. The oncologist 27 (5) (2022)